Steve Lombardi Moves from ABI to Affy to Helicos and Beyond, Green High-performance Computing, and More | GenomeWeb

Back in the November 2002 issue of Genome Technology, Steve Lombardi discussed his recent move from Applied Biosystems to Affymetrix. While he did not talk about what was thought to be an "involuntary departure" from ABI, he told GT that he was attracted to Affy by the idea of "getting back into genetic analysis and being involved from a corporate strategy perspective" — Lombardi's background is in DNA synthesis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.